American International Group’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,175
| Closed | -$145 | – | 3281 |
|
|
2021
Q1 | $145 | Buy |
1,175
+3
| +0.3% | – | ﹤0.01% | 2531 |
|
|
2020
Q4 | $133 | Sell |
1,172
-34
| -3% | -$4 | ﹤0.01% | 2506 |
|
|
2020
Q3 | $144K | Buy |
1,206
+301
| +33% | +$35.9K | ﹤0.01% | 2326 |
|
|
2020
Q2 | $113K | Buy |
905
+524
| +138% | +$65.4K | ﹤0.01% | 2461 |
|
|
2020
Q1 | $74K | Buy |
381
+246
| +182% | +$47.8K | ﹤0.01% | 2491 |
|
|
2019
Q4 | $45K | Sell |
135
-1
| -0.7% | -$333 | ﹤0.01% | 2907 |
|
|
2019
Q3 | $44K | Sell |
136
-1
| -0.7% | -$324 | ﹤0.01% | 2922 |
|
|
2019
Q2 | $59K | Buy |
137
+51
| +59% | +$22K | ﹤0.01% | 2904 |
|
|
2019
Q1 | $49K | Sell |
86
-2
| -2% | -$1.14K | ﹤0.01% | 2880 |
|
|
2018
Q4 | $26K | Sell |
88
-1
| -1% | -$295 | ﹤0.01% | 2996 |
|
|
2018
Q3 | $63K | Buy |
89
+31
| +53% | +$21.9K | ﹤0.01% | 3014 |
|
|
2018
Q2 | $34K | Buy |
58
+1
| +2% | +$586 | ﹤0.01% | 3026 |
|
|
2018
Q1 | $154K | Buy |
+57
| New | +$154K | ﹤0.01% | 2413 |
|